Clinical Trials Logo

Clinical Trial Summary

Background: Previous deployments like that to the Persian Gulf in 1991 produced veterans with post-deployment symptom-based health problems with no medical explanation. This was termed Gulf War illness or medically unexplained illness (MUI). If previous wars are any indication, some soldiers currently deployed to hostile areas also will return home with unexplained symptom-based illnesses. However, when this study began there was virtually no pre-war, prospective data on risk and resilience factors associated with MUI. This study is attempting to fill that gap.

Objectives: Our goals are to: (a) determine pre- and immediate post-deployment factors predicting later MUI and poor functional status, (b) improve previous methodological problems (e.g., selection bias, recall bias and lack of baseline controls) in studies of MUI, and (c) relate pre-deployment risk factors (e.g., personality, stressor reactivity) and resilience factors (e.g., coping style, social support) to post-deployment functional status.


Clinical Trial Description

Background: Previous deployments like that to the Persian Gulf in 1991 produced veterans with post-deployment symptom-based health problems with no medical explanation. This was termed Gulf War illness or medically unexplained illness (MUI). If previous wars are any indication, some soldiers currently deployed to hostile areas also will return home with unexplained symptom-based illnesses. However, was virtually no pre-war, prospective data on risk and resilience factors associated with MUI before 2001. This study will attempt to fill that gap. Objectives: Our goals are to: (a) determine pre- and immediate post-deployment factors predicting later MUI and poor functional status, (b) improve previous methodological problems (e.g., selection bias, recall bias and lack of baseline controls) in studies of MUI, and (c) relate pre-deployment risk factors (e.g., personality, stressor reactivity) and resilience factors (e.g., coping style, social support) to post-deployment functional status. Methods: This study uses a prospective, longitudinal observational design to assess risk and resilience factors for post-war MUI in Reserve and National Guard enlisted personnel. A stratified random sample of more than 700 subjects will be drawn from those undergoing pre- and post-mobilization readiness processing at Fort Dix, NJ and Camp Shelby, MS. Personnel will be tested pre-mobilization (Phase 1), immediately after mobilization (Phase 2) and at 3 months and 1 year post-deployment (Phases 3 & 4). Predictor variables include personality, social support, coping style, non-specific symptoms, sympathetic cardiac stress reactivity, and cortisol stress reactivity. Control variables include prior traumatic events, current distress, PTSD symptoms, socially desirable responding, body mass index, deployment experiences, environmental exposures and demographics (e.g., age, gender). Outcome variables include functional status, healthcare utilization, and MUI status (using CDC criteria for chronic multisymptom illness developed after the first Gulf War). Status: Publications and presentations are being prepared. Impact: The larger, prospective study with soldiers will help us to identify pre- and early post-deployment risk and resilience factors important in MUI, functional status, and healthcare utilization. There is an urgent need for both pre- and post-deployment predictors of later MUI uncontaminated by recall bias, and the selection bias of studying only treatment-seekers. If we are to understand how to best treat veterans presenting with unexplained symptoms, then we need to know which pre-war factors are most useful in predicting who is most likely to be resilient and who is most likely to be at risk for later unexplained illness. ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT00285246
Study type Observational
Source VA Office of Research and Development
Contact
Status Completed
Phase N/A
Start date December 2005
Completion date February 2011

See also
  Status Clinical Trial Phase
Completed NCT00990106 - Augmentation Trial of Prazosin for Post-Traumatic Stress Disorder (PTSD) N/A
Completed NCT00870545 - Reintegration: The Role of Spouse Telephone BATTLEMIND Pilot Study N/A
Completed NCT00419029 - Motivational Interviewing to Engage Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) Veterans in Mental Health Treatment N/A
Terminated NCT03736356 - Long-term Health Outcomes of AE Casualties
Completed NCT00371176 - A Placebo-Controlled Trial of D-Cycloserine and Exposure Therapy for Combat-PTSD N/A
Completed NCT02809326 - Trauma Management Therapy for OEF and OIF Combat Veterans Phase 2
Active, not recruiting NCT01216982 - Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders Phase 2
Completed NCT01049516 - Prolonged Exposure for Post Traumatic Stress Disorder (PTSD) Among Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) Personnel N/A
Completed NCT03934658 - Remote Study of NightWare for PTSD With Nightmares N/A
Completed NCT02556645 - A Comparison of Web-Prolonged Exposure (Web-PE) and Present-Centered Therapy (PCT) for PTSD Among Active-Duty Military Personnel N/A
Completed NCT00539279 - Treatment of Older Veterans With Chronic Posttraumatic Stress Disorder N/A
Completed NCT00974402 - Psychotherapy Treatment of Deployment-Related PTSD in Primary Care Settings N/A
Enrolling by invitation NCT04040387 - Traumatic Nightmares Treated by NightWare (To Arouse Not Awaken) N/A
Active, not recruiting NCT02825602 - Vietnam Era Health Retrospective Observational Study
Completed NCT02266329 - Chronic Postconcussive Headache: A Placebo-Controlled Treatment Trial of Prazosin Phase 1/Phase 2
Completed NCT02226367 - Prazosin Augmentation of Outpatient Treatment of Alcohol Use Disorders in Active Duty Soldiers With and Without PTSD N/A
Terminated NCT01062022 - FOCUS-CI: A Preventive Intervention With Children and Families of the Combat Injured N/A
Completed NCT00475241 - Exposure Therapy for Chronic PTSD: Efficacy and Mechanisms Phase 2/Phase 3
Completed NCT00292370 - Quetiapine Augmentation for Treatment-resistant PTSD Phase 4
Completed NCT03795987 - Traumatic Nightmares Treated by NightWare (To Arouse Not Awaken) N/A